Idexx Laboratories (IDXX) Capital Expenditures (2009 - 2026)

Idexx Laboratories' Capital Expenditures history runs 18 years deep, the most recent figure standing at $8.3 million for Q1 2026.

• In Q1 2026, Capital Expenditures fell 72.44% year-over-year to $8.3 million; the TTM figure through Mar 2026 stood at $102.9 million (down 24.19% YoY), while the FY2025 annual figure was $124.7 million, up 3.1% from the prior year.
• Capital Expenditures was $8.3 million for Q1 2026 at Idexx Laboratories, down from $117.9 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $117.9 million in Q4 2025 to a low of -$57.4 million in Q3 2025.
• Historically, Capital Expenditures has averaged $31.5 million across 5 years, with a median of $30.0 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Capital Expenditures jumped 8166.27% in 2023, then tumbled 168.81% in 2025.
• A 5-year view of Capital Expenditures shows it stood at $49.2 million in 2022, then sank by 33.87% to $32.6 million in 2023, then slipped by 10.14% to $29.3 million in 2024, then jumped by 303.0% to $117.9 million in 2025, then slumped by 92.98% to $8.3 million in 2026.
• The last three Capital Expenditures figures came in at $8.3 million (Q1 2026), $117.9 million (Q4 2025), and -$57.4 million (Q3 2025), per Business Quant data.